Dual occurrence of ALK G1202R solvent front mutation and small cell lung cancer transformation as resistance mechanisms to second generation ALK inhibitors without prior exposure to crizotinib. Pitfall of solely relying on liquid re-biopsy?
Titel:
Dual occurrence of ALK G1202R solvent front mutation and small cell lung cancer transformation as resistance mechanisms to second generation ALK inhibitors without prior exposure to crizotinib. Pitfall of solely relying on liquid re-biopsy?
Auteur:
Ou, Sai-Hong Ignatius Lee, Thomas K. Young, Lauren Fernandez-Rocha, Maria Y. Pavlick, Dean Schrock, Alexa B. Zhu, Viola W. Milliken, Jeffrey Ali, Siraj M. Gitlitz, Barbara J.